Get started
Laurus Labs Ltd.Laurus Labs Ltd.Laurus Labs Ltd.

Laurus Labs Ltd.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs
Full chart
Full chart

Compare with Laurus Labs Ltd.



Key stats


Market capitalization
‪1.07 T‬ INR
Dividend yield (indicated)
0.10%
Price to earnings Ratio (TTM)
97.95
Basic EPS (TTM)
20.25 INR
Net income (FY)
‪8.89 B‬ INR
Revenue (FY)
‪68.13 B‬ INR
Shares float
‪374.67 M‬
Beta (1Y)
0.49

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪13.83 K‬
Change (1Y)
‪+1.36 K‬+10.95%
Revenue / Employee (1Y)
‪4.93 M‬ INR
Net income / Employee (1Y)
‪642.56 K‬ INR

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Satyanarayana Chava
Website
lauruslabs.com
Headquarters
Hyderabad
Founded
2005
IPO date
Dec 19, 2016
ISIN
INE947Q01028
FIGI
BBG00FFGJFX4
Identifiers
ISIN INE947Q01028
CFI code
ESVUFN
Laurus Labs Ltd. develops and manufactures active pharmaceutical ingredients for therapeutic areas of anti-retrovirals and hepatitis C. The company was founded by Dr. Satyanarayana Chava on September 19, 2005 and is headquartered in Hyderabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral

Analyst rating


An aggregate view of professional's ratings.
Neutral
Neutral
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight0.02%
Market value‪108.84 M‬
VWO
Vanguard FTSE Emerging Markets ETF
Weight0.06%
Market value‪104.13 M‬
IEMG
iShares Core MSCI Emerging Markets ETF
Weight0.05%
Market value‪84.34 M‬
INDA
iShares MSCI India ETF
Weight0.56%
Market value‪32.17 M‬
IIND
iShares MSCI India UCITS ETF
Weight0.55%
Market value‪26.77 M‬
EIMU
iShares Core MSCI EM IMI UCITS ETF
Weight0.05%
Market value‪24.54 M‬
EIMI
iShares Core MSCI EM IMI UCITS ETF
Weight0.05%
Market value‪24.54 M‬
CGNG
Capital Group New Geography Equity ETF
Weight0.68%
Market value‪21.32 M‬
EMXC
iShares MSCI Emerging Markets ex China ETF
Weight0.07%
Market value‪18.83 M‬
EEM
iShares MSCI Emerging Index Fund
Weight0.06%
Market value‪18.20 M‬
VEU
Vanguard FTSE All World Ex US ETF
Weight0.02%
Market value‪17.60 M‬

Explore more ETFs 

Frequently asked questions


The current price of LAURUSLABS is 1,989.00 INR — it has increased by 0.37% in the past 24 hours. Watch Laurus Labs Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Laurus Labs Ltd. stocks are traded under the ticker LAURUSLABS.
LAURUSLABS stock has fallen by −1.54% compared to the previous week, the month change is a 5.01% rise, over the last year Laurus Labs Ltd. has showed a 137.24% increase.
We've gathered analysts' opinions on Laurus Labs Ltd. future price: according to them, LAURUSLABS price has a max estimate of 1,990.00 INR and a min estimate of 1,125.00 INR. Watch LAURUSLABS chart and read a more detailed Laurus Labs Ltd. stock forecast: see what analysts think of Laurus Labs Ltd. and suggest that you do with its stocks.
LAURUSLABS reached its all-time high on Sep 24, 2026 with the price of 2,054.55 INR, and its all-time low was 59.60 INR and was reached on Aug 7, 2019. View more price dynamics on LAURUSLABS chart.
See other stocks reaching their highest and lowest prices.
LAURUSLABS stock is 2.78% volatile and has beta coefficient of 0.49. Track Laurus Labs Ltd. stock price on the chart and check out the list of the most volatile stocks — is Laurus Labs Ltd. there?
Today Laurus Labs Ltd. has the market capitalization of ‪1.07 T‬, it has increased by 0.34% over the last week.
Yes, you can track Laurus Labs Ltd. financials in yearly and quarterly reports right on TradingView.
Laurus Labs Ltd. is going to release the next earnings report on Oct 22, 2026. Keep track of upcoming events with our Earnings Calendar.
LAURUSLABS earnings for the last quarter are 6.80 INR per share, whereas the estimation was 4.91 INR resulting in a 38.44% surprise. The estimated earnings for the next quarter are 5.58 INR per share. See more details about Laurus Labs Ltd. earnings.
Laurus Labs Ltd. revenue for the last quarter amounts to ‪20.26 B‬ INR, despite the estimated figure of ‪18.35 B‬ INR. In the next quarter, revenue is expected to reach ‪20.13 B‬ INR.
LAURUSLABS net income for the last quarter is ‪3.68 B‬ INR, while the quarter before that showed ‪2.79 B‬ INR of net income which accounts for 0.00% change. Track more Laurus Labs Ltd. financial stats to get the full picture.
As of Oct 2, 2026, the company has ‪13.83 K‬ employees. See our rating of the largest employees — is Laurus Labs Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Laurus Labs Ltd. EBITDA is ‪20.34 B‬ INR, and current EBITDA margin is 26.45%. See more stats in Laurus Labs Ltd. financial statements.
Like other stocks, LAURUSLABS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Laurus Labs Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Laurus Labs Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Laurus Labs Ltd. stock shows the buy signal. See more of Laurus Labs Ltd. technicals for a more comprehensive analysis.